Casali, L.

Collins, John

Fritz, Hans

Grassi, C.

Jochum, Marianne

Luisetti, M.

Travis, J.

English

Universität München: Elektronischen Publikationen

Proteinase inhibitor candidates for therapy of enzyme-inhibitor imbalances

Open Access LMU

Acquired antithrombin III deficiency: laboratory diagnosis, incidence, clinical implications, and treatment with antithrombin III concentrate.

Amino acid sequence elucidation of human acrosin-trypsin inhibitor (HUSI-II) reveals that Kazal-type proteinase inhibitors are structurally related to ß-subunits of glycoprotein hormones. FEBS Lett.

Bestimmung von Aprotinin-Plasmakonzentrationen nach therapeutischer Anwendung von Trasylol. In: DudziakR.,

Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs.

Cathepsin L inactivates o^-proteinase inhibitor by cleavage in the reactive site region.

Characterization of two proteinase inhibitors from human seminal plasma and spermatozoa. In: Fritz H., Tschesche H., Greene L.J., Truscheit E.: Proteinase Inhibitors.

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

Design of efficient human leukocyte elastase inhibitors: Variants of human pancreatic secretory trypsin inhibitor (hPSTI).

Direct effects of neutrophil oxidants on elastase-induced extracel lular matrix proteolysis.

Elastase and its inhibitors in intensive care medicine.

Expression of human a,-antitrypsin using a recombinant adenovirus vector. FEBS Lett.

HealyJ.T,Czerski D.B.,CrystalR.G.: Recombinant DNA-produced alpha^antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with α,-antitrypsin deficiency.

Human leukocyte elastase inhibitors: Designed variants of human pancreatic secretory trypsin inhibitor (hPSTI).

Human mucus proteinase inhibitor (human MPI). Human seminal inhibitor 1 (HUSI-I), antileukoprotease (ALP), secretory leukocyte protease inhibitor (SLPI).

Human pancreatic secretory trypsin inhibitor (PSTI) produced in active form and secreted from &quot;Escherichia coli&quot;. Gene

Inhibitors of leukocyte elastase and leukocyte cathepsin G. Agents for the treatment of emphysema and related ailments.

Inter- a- Τrypsininhibitor und Carboxypeptidase N. Aufldärung der Primärstrukturen und Konstruktion varianter Proteine. Habilitation thesis. The Ludwig-Maximilians-University of Munich,

Inter-a-trypsin inhibitor and its close relatives. In: Barrett

Inter-a-trypsin inhibitor is acomplex of three different protein species.

Isolation of a crystalline trypsin-inhibitor anticoagulant protein from pancreas.

K.M.: Reduction in blood loss and blood use after cardiopul monary bypass with high dose aprotinin (Trasylol).

Kato I.: Protein inhibitors of proteinases.

L.J.: The primary structure of the human pancreatic trypsin inhibitor.

Neue Serinprotease-lnhibitor-P rot eine, diese enthaltende Arzneimittel und DNA-Sequenzen, die für diese

Pathobiochemical mechanisms in inflammation. In:

Potential problems in designing elastase inhibitors for therapy.

Protein inhibitors of serine proteinases-Mechanism and classification. In: Friedman M. (Ed.): Nutritional and toxicological significance of enzyme inhibitors in foods.

R.W.: A genetically engineered mutant of α,-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease. Lancet

Recombinant human secretory leukocyte-protease inhibitor: In vitro properties and amel ioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster.

Recombinant α,-antitrypsin Pittsburg (Met 8 Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.

Sebening F.: Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in open-heart surgery.

SinhaS.: The secreted form of the Alzheimer's amyloid precursor 112 protein with the Kunitz domain is protease nexin II. Nature

Smith H.J.(Eds.): Design of Enzyme Inhibitors as Drugs.

St.J.: Oxidative regulation of neutrophil elastase-alphaj-proteinase inhibitor interactions.

The construction of novel protease inhibitors by modification of the active centre of

Weiss St.J.: Proteolytic inactivation of α,-proteinase inhibitor by a neutrophil metalloproteinase.

α,-Antitrypsin deficiency, emphysema, and liver disease.

https://epub.ub.uni-muenchen.de/9431/1/9431.pdf

Proteinase inhibitor candidates for therapy of enzyme-inhibitor imbalances

Abstract

Similar works

Full text

Available Versions

Universität München: Elektronischen Publikationen

Open Access LMU